SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 18th, 2019 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 18th, 2019 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 17, 2019, between Innovate Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).